Astria Therapeutics Inc (ATXS) valuation · $382.1M cap
Astria Therapeutics Inc (ATXS) $382.1M cap.
| Metric | Value |
|---|---|
| Market cap | $382.1M |
| Revenue | $706.0K |
| P/S | 541.2 |
ATXS valuation FAQ
What is ATXS's market cap?
Astria Therapeutics Inc (ATXS) market cap is $382.1M on the latest cached fundamentals snapshot.
What is ATXS's latest revenue?
Latest cached Astria Therapeutics Inc (ATXS) revenue was $706.0K. Statements: https://lician.com/financials/atxs
What is ATXS's price-to-sales ratio?
Astria Therapeutics Inc (ATXS) price-to-sales (P/S) is 541.2, cached market cap $382.1M divided by revenue $706.0K.
How many ATXS valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for Astria Therapeutics Inc (ATXS): Market cap, Revenue, and P/S.
Where is ATXS valuation listed?
Cached valuation multiples for Astria Therapeutics Inc (ATXS) are listed at https://lician.com/valuation/atxs.
Not investment advice. Cached rows, not a live tape.